Cafepharma Today

May 28 2025 - GLP-1 prescriptions for weight loss soar, despite obstacles
GLP-1 prescriptions for weight loss soar, despite obstacles
FDA approves use of Sanofi's meningococcal vaccine in infants
GSK's $66M bet on Spero's rejected UTI antibiotic pays off with a phase 3 win
AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Wallops Profit, Sales Estimates
TheStreet.com
Tuesday, August 3, 2010 - 8:25am
tags:
Pfizer, earnings
Sanofi sends $69/share offer to Genzyme: sources
Yahoo/Reuters
Tuesday, August 3, 2010 - 8:22am
tags:
M&A, Sanofi, Genzyme, GSK, JNJ
Where Does the WuXi Deal Breakup Leave Charles River?
Seeking Alpha
Tuesday, August 3, 2010 - 8:19am
tags:
Charles River Laboratories, M&A, WuXi PharmaTech
Jazz Pharma - FDA Panel Prep
TheStreet.com
Tuesday, August 3, 2010 - 8:17am
tags:
FDA, advisory panels, Jazz Pharmaceuticals, fibromyalgia, JZP-6
Allergan's Botox Migraine Review Extended Three Months by U.S. Regulators
Bloomberg
Monday, August 2, 2010 - 8:34pm
tags:
Allergan, FDA, migraines, Botox
What Investors Think About Alexion Pharmaceuticals
Motley Fool
Monday, August 2, 2010 - 8:31pm
tags:
Alexion
Momenta cuts loss
Bizjournals.com
Monday, August 2, 2010 - 8:17pm
tags:
earnings, Momenta
Merck, Stallergenes race to FDA with new allergy treatments
Fierce Biotech
Monday, August 2, 2010 - 8:15pm
tags:
Merck, Stallergenes, FDA, allergies, Grazax, Oralair, sublingual treatments
Can Roche Handle the Truth? “A Few Good Men” Case Could Expose Acne Drug Dangers
BNET Pharma
Monday, August 2, 2010 - 8:12pm
tags:
Roche, Accutane
Sanofi-Aventis in acquisition talks with Genzyme: WSJ
Marketwatch
Monday, August 2, 2010 - 8:09pm
tags:
Genzyme, M&A, Sanofi
Cardioxyl gets $15M and positive data on lead program
Fierce Biotech
Monday, August 2, 2010 - 10:41am
tags:
Cardioxyl, clinical trials, funding
AstraZeneca Settlement Terms in Almost 4,000 Seroquel Cases to Stay Secret
Bloomberg
Monday, August 2, 2010 - 10:38am
tags:
antipsychotics, settlements, AstraZeneca, Seroquel
Pediatric Exclusivity for Viagra?! It's No Joke
InVivo
Monday, August 2, 2010 - 10:33am
tags:
Viagra, Pfizer, pediatrics, PAH, Revatio
Massachusetts Gift Ban For Doctors Remains Intact
Pharmalot
Monday, August 2, 2010 - 10:32am
tags:
physician gifts, Massachusetts
MannKind 2Q loss narrows on lower costs
Yahoo/AP
Monday, August 2, 2010 - 10:30am
tags:
MannKind, earnings
More Genzyme Buyout Estimates Rolling In
Yahoo/IndieResearch
Monday, August 2, 2010 - 10:29am
tags:
Genzyme, M&A, Sanofi, JNJ, GSK
How will your Pharma Company do with Healthcare Reform?
Pharmareform
Monday, August 2, 2010 - 10:24am
tags:
healthcare reform
Sanofi May Make Hostile Bid If Genzyme Resists, Citigroup Says
Bloomberg
Monday, August 2, 2010 - 10:23am
tags:
M&A, Genzyme, hostile takeover, Sanofi
Astellas Cuts Profit Outlook, Says Earnings May Fall Further on OSI Costs
Bloomberg
Monday, August 2, 2010 - 10:22am
tags:
earnings, Astellas, M&A, OSI Pharmaceuticals
Report: Watson flirts with Sigma offer
Fierce Pharma
Monday, August 2, 2010 - 10:20am
tags:
Watson Pharmaceuticals, Sigma, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.